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Abstract
Purpose This study examined economic costs associated with untreated eating disorders (EDs) characterised by regular binge 
eating in the absence of low weight. Both direct and indirect costs were assessed, reporting a limited societal perspective of 
economic impact as some costs were not included.
Methods One hundred and twenty six adults seeking treatment for recurrent binge eating were asked to report impairment 
associated with an ED. Costs were calculated using 2017 prices, including an examination of variables associated with costs.
Results Estimated societal costs for the year preceding assessment were £3268.47 (€3758.54) per person. In multivariate 
analyses, no reliable baseline associates of cost were identified.
Conclusion The economic burden of EDs characterised by regular binge eating is significant, and underscores the need for 
efficacious and cost-effective treatments. Individuals with binge-eating disorders report work impairment and healthcare 
use that may cost the United Kingdom economy upwards of £3.5 billion (€4bn) per annum. Further studies should consider 
academic impairment and the economic impact of EDs on families.
Level of evidence III: evidence obtained from well-designed cohort or case–control analytic studies.
Keywords Healthcare costs · Healthcare utilisation · Binge eating · Impairment
Introduction
Attention paid to the economic burden of eating disorders 
(EDs) has been increasing, particularly over the last two dec-
ades [1]. Given the significant morbidity associated with 
EDs, attempts have been made to estimate cost-of-illness, 
covering both ‘direct’ and ‘indirect’ costs, often referred to 
as taking a societal perspective [2]. Direct costs encompass 
healthcare and non-healthcare costs involved in the treat-
ment and care of an illness and indirect costs provide an 
estimate of economic resources lost because of impaired 
productivity (e.g., employment-related). In addition, ‘psy-
chosocial’ costs assess the (often intangible) impact of an 
illness on quality of life or well-being and are perhaps the 
least well-understood contributor to economic burdens. The 
societal perspective, which typically includes an assessment 
of all relevant costs, informs policies and evaluations aimed 
at maximising welfare gains, considering impacts on both 
healthcare and wider society [3]. Thus, although costs can 
be usefully categorised in several ways (e.g., resources for 
medical and non-medical care), economic reporting within 
the societal perspective proceeds regardless of who bears 
this cost [3].
Reviews of cost-of-illness studies in EDs have under-
lined heterogeneity in samples and methods used, resulting 
in wide variation in estimated costs [1, 4] (see also [5]). A 
large proportion of studies originate from North America 
and many obtain cost information from health insurance 
databases (see also [6]), which can be affected by sampling 
bias as well as variable insurance coverage across regions 
[4]. There has been limited consideration of wider costs, 
and studies have underestimated economic impact [1], rarely 
covering factors such as work absence [4]. Research taking 
a societal perspective is often lacking [1], meaning that the 
true cost-of-illness may be underestimated and costs relevant 
to the wider impact of EDs overlooked.
Comparatively little is known about the economic 
impact of regular binge eating, with a shortage of pub-
lished studies from the United Kingdom (UK) (and 
Europe), where accessibility of healthcare is underpinned 
by universal coverage or state-funded services, often ‘free 
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at the point of delivery’. Individuals with regular binge 
eating who are not underweight represent the majority 
of those with EDs presenting for outpatient treatment [7] 
and are rarely afforded consideration as a distinct group 
in cost-of-illness studies, although might be partially cap-
tured in studies including different types of EDs (e.g., [6, 
8]). Existing work has tended to focus on one particular 
illness rather than considering a range of ED presentations 
[1, 6, 8–11], with studies of anorexia nervosa particularly 
common.
Healthcare use for non-underweight individuals who 
report regular binge eating is higher than that for individu-
als without EDs [10, 12, 13], even when accounting for 
comorbidities [6, 14]. When examining economic impact, 
annual healthcare costs for bulimia nervosa (BN) range 
from €888 to €18,823, and €1762 to €2902 for individuals 
with binge-eating disorder (BED) [15], with societal costs 
seldom reported [16] (but see [5, 17, 18]). Data on indi-
viduals with subthreshold EDs and those with a diagnosis 
of other specified feeding and eating disorder (OSFED) 
are notably lacking given the estimated prevalence of these 
syndromes and the associated impairment and cost [19].
Although some studies have examined the influence of 
demographic factors, such as age and gender (e.g., [6, 11]), 
few have explored whether common ED symptoms, such 
as binge eating, are associated with costs, which can help 
inform both healthcare and research priorities. Looking 
at a sample of women seeking treatment for regular binge 
eating, Dickerson et al. [20] found that baseline binge eat-
ing frequency was not associated with costs, although age 
was positively related to both medication costs and total 
healthcare costs. Higher body mass index (BMI) was posi-
tively associated with medication costs (see also [5]).
A 2015 report commissioned by a UK ED charity [21] 
suggested an annual cost of between £2.6 billion and 
£3.1bn to sufferers and carers, with costs to the National 
Health Service (NHS) of between £3.9bn and £4.6bn. A 
report of societal costs to the US in 2018–2019 [5] esti-
mated costs exceeding $64bn (equivalent to $11,808 [~ 
€9784] for each person with an ED). Similar estimates 
have been made in other countries (e.g., [16, 22]) and 
outline the significant financial burden of EDs although 
further work is required to explore and triangulate these 
findings [22].
The current study aims to estimate societal costs in a 
group of non-underweight individuals referred for special-
ist outpatient treatment for regular binge eating, using a 
prevalence-based, ‘bottom–up’ approach (i.e., obtaining 
cost data directly from patients via self-report). Addition-
ally, the study will look at associations between costs, 
demographic factors, and binge eating, as well as explor-
ing diagnostic differences (e.g., [13, 14, 23]).
Materials and methods
Participants
Participants were 126 adults referred to one of three special-
ist ED services in the UK, covering a population of around 
1.3 million adults across Buckinghamshire, Oxfordshire, 
and Wiltshire. (A recent report [24] compiled a directory 
of 56 similar services across England.) Individuals who, 
at assessment with the service, met criteria for a diagnosis 
of BN, BED, or OSFED participated in a randomised con-
trolled trial of guided self-help with few exclusion criteria 
(see [25]), and data from these individuals were included 
in the current study (see Table 1). Conduct of the trial was 
approved by an ethics review board (details are reported 
elsewhere [26]) and the study was performed in accordance 
with the ethical standards as laid down in the 1964 Declara-
tion of Helsinki and its later amendments.
Healthcare utilisation
A questionnaire was designed for this study, completed 
retrospectively by participants (see [25]). Although 
Table 1  Demographic and clinical characteristics of individuals with 
non-underweight binge-eating disorders
N = 126, except where indicated
a All identified with either male or female gender
b = 113
c N = 123
Variable Value
Gender, female:malea 118:8
Age, years: mean (SD) 30.20 (10.24)
Duration of illness, years: mean (SD)b 11.44 (9.87)













 Bulimia nervosa: n (%) 76 (60.3)
 Binge-eating disorder: n (%) 27 (21.4)
 Other specified feeding and eating disorder: n (%) 23 (18.3)
Employment status
 Employed: n (%) 80 (63.5)
 Unemployed: n (%) 7 (5.6)
 Full-time student: n (%) 34 (27.0)
 Other: n (%) 5 (4.0)
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self-report methods of estimating economic impact can 
be challenging, it is recommended that they consider: a 
recall time frame of 6 months or less; resource utilisation 
frequency; and type of utilisation [27, 28]. The question-
naire asked participants about healthcare utilisation over 
the previous 3 months and to estimate of the amount of 
time lost from work or education (i.e., absenteeism) and 
reduced productivity (i.e., presenteeism). Information was 
requested regarding medical investigations and out-of-
pocket expenses for attending appointments, specifically 
travel costs. Centralised NHS records were not accessed, 
although information about medication use was obtained 
from patient records.
The suggestions of Jo [2] were used as to guide economic 
analyses, although shortcomings in the methods meant that 
some costs (e.g., regarding carers, social care, foregone 
leisure activities) were not gathered and so the estimate is 
referred to as being from a ‘limited societal’ perspective 
[3]. As the questionnaire covered a 3-month period, annual 
figures are provided, including an estimate of the cost to 
society through multiplying annual costs per patient by the 
prevalence of binge eating problems (1.6%) in a sample of 
the population of England [29]. Cost data are reported in 
pound sterling (GBP), with summaries converted to Euros 
for comparative purposes (using a rate of £1:€1.15 [May 6 
2021]).
Estimating unit costs
Total costs were calculated by taking the average usage for 
the sample and multiplying this by the unit cost. Prices were 
obtained through either (1) the Unit Costs of Health and 
Social Care [30] or (2) a policy paper regarding NHS refer-
ence costs 2013–2014 [31]; the latter was adjusted to 2017 
prices using the Consumer Price Index rate (details from 
[32]). Cost details are provided in Online Resource 1 cover-
ing several types of appointment. Where participants stated 
that they used a service but did not specify the number of 
visits, a value of “1” was given, which is likely to underes-
timate use.
In the UK, individuals are entitled to healthcare which 
is free at the point of access. For example, appointments 
with a primary care physician or attendance at Accident and 
Emergency departments will generally be free of charge to 
the patient. Some interventions (e.g., medications) do incur 
a charge although some individuals (e.g., women who are 
pregnant or who have had a baby in the last year) are entitled 
to free prescriptions.
Work and study impairment
Absenteeism costs were estimated from responses to the 
question: “How many full days have you lost from work 
due to eating disorder symptoms or concerns in the last three 
months?” As presenteeism, defined as reduced productivity 
whilst at work, is more complex to estimate, this was based 
on a study of individuals with BED [33] reporting around 
30% of time lost due to impaired productivity. Thus, if a 
participant reported 10 days of reduced productivity (“How 
many full days of reduced productivity have you experienced 
while at work due to eating disorder symptoms or concerns 
in the last three months?”), this was ‘costed’ as the equiva-
lent of three days of lost work. (A ratio of around 1:2.1 was 
estimated in a study of depression [34]). Study impairment 
is presented as number of full days lost and days affected 
by reduced productivity regarding education; no economic 
estimates are attributed to this.
To calculate costs, the Human Capital Method was used 
(see [2, 35]). This involved taking the number of days missed 
in the last three months, multiplying this by the equivalent 
mean wage (£16.63 per h,1 based on that of a female in her 
early 30 s [36]) and extrapolating for 1 year. Some individu-
als provided data for productivity costs but not direct costs 
and were excluded from primary analyses but included in a 
sensitivity analysis, with missing data (typically regarding 
travel) costed as 0 (see Online Resource 2). A further sensi-
tivity analysis (Online Resource 3) used different prevalence 
rates for men (0.5%) and women (2.5%) [29] and a third 
(Online Resource 4) adjusted wage estimates by gender. A 
fourth sensitivity analysis was based on medication use and 
assumed a single unit cost for medication (Online Resource 
5).
Binge eating frequency was taken from the Eating Dis-
order Examination Questionnaire (EDE-Q; [37]), collected 
at the same time as cost data. Therefore, the timeframe of 
cost estimates was longer than that assessed by the EDE-Q 
(28 days), meaning that temporal precedence cannot be 
determined.
Statistical analyses
Kolmogorov–Smirnov tests for the normality of vari-
able distribution were significant for costs (ps < 0.01). The 
Kruskal–Wallis H Test was used to look at group differ-
ences and the generalised linear model (GLM) with gamma 
probability distribution and log link function was used to 
explore associations with binge eating when controlling for 
covariates (age, BMI, gender). Only main effects were con-
sidered given small sample sizes and issues with interpreting 
interaction terms in some GLMs (see [38]). Estimates of 
societal costs are provided alongside bootstrap-based 95% 
confidence intervals (CIs) [4].
1 This equates to £623.63 per week. Median gross weekly earnings 
for full-time employees across the UK in 2017 was £550 [36].
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Results
Healthcare use and associated costs are provided in 
Table 2. Inpatient costs were zero as no patients were 
admitted in the three months prior to assessment. Most 
participants had contacted a primary care physician and 
over half had undergone investigations such as blood tests. 
Just over one-quarter had taken psychotropic medication.
Work absenteeism was reported by 40.0% of partici-
pants and 60.0% reported missing days of study/education 
(see Table 3). The majority of participants reported at least 
some work (n = 24; 84.5%) or study (n = 19; 82.6%) pres-
enteeism. Eleven individuals gave information regarding 
both work and study.
Out‑of‑pocket expenses
Costs were estimated based on travel to the Eating Disorders 
Service (EDS), with mileage costs based on £0.40 (€0.46) 
per mile travelled. Participants mentioned costs associated 
with missing work to attend appointments although this was 
sporadic and therefore not included.
Seventy-five individuals provided data on out-of-pocket 
expenses, of whom 28 (37.3%) cited no costs to themselves; 
for example, some used modes of transport from which run-
ning costs were not estimated (e.g., bicycle). As such, this 
is likely to be an underestimate of cost impact for patients, 
as costs to attend other appointments (e.g., blood tests) and 
possible medication charges were not included. Estimated 
Table 2  Summary of healthcare resource use and estimated costs associated with binge-eating disorders (N = 126)
a Participants could report > 1 investigation and could specify the frequency (e.g., “two blood tests”). One participant reported having received an 
investigation but did not disclose its nature (so was costed as zero)
NK not known
Domain % with any use Total no. of 
visits (last 
3 months)
Mean no. of con-
tacts for users (last 
3 months)
Unit cost Cost per 
person per 
year
Component as % of total 
annual healthcare cost
Primary care physician 74/86 (86.0%) NK 1 £38.00 £130.80 16.03%
Other healthcare professional 31/84 (36.9%) 61 0.73 £39.00 £113.88 13.96%
Accident and emergency depart-
ment
3/84 (3.6%) 13 0.15 £106.42 £65.88 8.08%
Medication
 Antidepressants 33/126 (26.2%) – – £15.66 £16.40 2.01%
 Other 3/126 (2.4%) – – £24.33 £2.32 0.28%
 Additional costs (e.g., dispens-
ing)
36/126 (28.6%) – – £385.20 £440.24 53.97%
Medical  investigationsa
 Blood tests 45/85 (52.9%) 47 0.55 £8.41 £18.60 2.28%
 Cardiac investigations 7/85 (8.1%) 7 0.08 £40.97 £13.48 1.65%
 Bone density 3/85 (3.5%) 3 0.04 £72.32 £10.20 1.25%
 Other 4/85 (4.7%) 4 0.05 £21.00 £3.96 0.49%
 Subtotal – – – – (£46.24) (5.67%)
Table 3  Lost work and study 
productivity estimates (mean 
[SD]) for non-underweight 
individuals with binge eating
a If data were missing from only one question, the cost is included in the total
Domain Na Days (last 3 months) Annual days Estimated cost per annum
Work
 Absenteeism 77 1.88 (4.12) 7.52 (16.48) £937.41 (2062.03)
 Presenteeism 76 14.22 (19.66) 56.88 (78.64) £2046.72 (2916.47)
 Total 77 – – £2957.55 (3813.29)
Study
 Absenteeism 25 9.40 (18.60) 37.60 (74.40) –
 Presenteeism 23 28.70 (26.23) 114.78 (104.91) –
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 
1 3
out-of-pocket expenses for the previous 3 months varied 
from zero to £60, and were not extrapolated for the year as 
the majority related to attendance for assessment at the EDS.
Costs by diagnosis
Costs by DSM-5 diagnosis [39] are presented in Table 4. 
Societal cost was estimated at £3268.47 (€3758.74) per per-
son per annum across binge-eating disorders, with similar 
estimates and trends observed in sensitivity analyses (range 
for societal costs = £3169.87–£3316.14).
Correlates of costs
Overall regression models (including age, BMI, gender, 
binge eating frequency) were not significant for any costs 
(ps > 0.05). Costs by age group are presented in Online 
Resource 4.
Discussion
The current study reports cost-of-illness data for adults 
referred for treatment of recurrent binge eating in the 
absence of significantly low body weight. Estimated costs 
to society were £3268.47 (€3758.74) per individual per 
annum, with similar findings obtained through sensitivity 
analyses. Tangible costs borne by UK society for individuals 
with such presentations equate to around £3.47bn per year; 
a sensitivity analysis (changing the estimate of prevalence) 
produced a figure of just over £3.1bn. These figures indicate 
the significant burden of non-underweight EDs; in 2010, for 
example, the UK societal cost of all anxiety disorders was 
estimated to be around €11.7bn and €1.6bn for epilepsy; 
[40]). Results should be considered indicative (rather than 
exact) and taken alongside those of other studies—such as 
appraisals obtained from health insurance databases [6, 13], 
prevalence-based reviews of existing data [5], and surveys 
[11, 17]—to estimate the overall economic impact of the 
full range of EDs.
Previous societal estimates have suggested that costs of 
EDs range between €10,000 and €14,000 per person per year 
and, around a decade ago, Mitchell et al. [23] estimated that 
individuals with EDs incur costs of around US$4000 (2005 
prices) in the year preceding diagnosis, close to the current 
estimate (see also [13]). Costs of US$9541 [5] (~ €7946) per 
person per year have been attributed to BED, for example, 
although higher estimates have been noted (e.g., [16, 17]).
Around 8 million days of work may be lost through 
absenteeism in the UK per year, and an even greater number 
through presenteeism, due to binge eating problems. Find-
ings are comparable to those regarding other psychiatric dis-
orders (e.g., around nine annual days lost per worker with 
depression [34]), and economic reports in the US and else-
where have estimated that 75% of the overall cost of EDs is 
attributable to productivity losses [5]. Given that the current 
cost estimate of presenteeism was based on previous work 
[33], which has also been the case in a recent US study [5], 
more work is needed to clarify productivity losses attribut-
able to EDs. Assessment of academic impairment (see also 
[41]) suggested that around 40 days of study time per year 
are lost for each individual with a non-underweight binge-
eating disorder. Study presenteeism was also high, although 
sample sizes were small. Given that academic impairment 
has rarely been considered in cost-of-illness studies [1], this 
area warrants further research.
Findings regarding multivariate models of costs were in 
line with some existing work (e.g., [11]) and no diagnostic 
differences were observed in cost estimates (see also [14, 
23]). Although costs appeared to be lower in the oldest group 
(see also [5]), the lack of significant findings may have been 
influenced by sample size, with analyses not sufficiently 
powered to detect small correlations. In addition to larger 
samples, further research should consider other covariates, 
such as depression, given the contribution of comorbidity to 
higher cost estimates (e.g., [11, 20]).
Whilst the small sample size should be noted, men 
incurred lower societal costs than women (see Online 
Material 3) and, although the gender ratio is in line with a 
UK study conducted in primary care [42], men were likely 
underrepresented in the current study and the true cost 
Table 4  Estimated costs of non-underweight binge-eating disorders by total sample and DSM-5 diagnosis, per individual per year
All tests ns
Costs, mean (SD)
Diagnosis Healthcare use Out-of-pocket Productivity Societal Bootstrapped societal 95% CIs
Total sample £474.29 (631.42) £10.62 (12.76) £2957.55 (3813.29) £3268.47 (3985.74) £2421.15–£4218.38
BN £529.44 (784.78) £8.95 (12.89) £3246.88 (4172.74) £3559.07 (4448.88) £2336.23–£5078.95
BED £376.40 (312.99) £13.95 (10.81) £1757.69 (2527.47) £2144.08 (2475.77) £1121.62–£3432.92
OSFED £405.96 (192.83) £12.33 (13.95) £3366.00 (3671.25) £3702.12 (3798.21) £1861.18–£5699.20
H (df = 2) 1.456 4.204 1.849 1.596 N/A
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impact of men with EDs may be notably underestimated, 
particularly given wage imbalances (e.g., see [5]). Much 
of the cost burden of healthcare noted in previous studies 
has been attributed to inpatient admission, with the average 
cost of a hospitalised individual approximately four times 
that of someone not admitted [1]. Although only a minority 
of individuals with binge-eating disorders receive hospital 
treatment [43], the current study assumed zero costs due to 
non-emergency admissions and additional reports of cost 
estimates for those commonly seen in outpatient clinics are 
needed.
The current estimates, whilst substantial and in line with 
some studies, are less than those presented in a recent report 
commissioned by a UK eating disorder charity [21] and 
those in other countries [5, 16, 22]. This is likely a result of 
several factors. First, only ‘tangible’ costs (e.g., healthcare, 
productivity) were included in the current study, with no 
assessment of the impact on wellbeing (see [5, 16]). Second, 
children with regular binge eating, individuals with anorexia 
nervosa, and costs to carers were not included.
Strengths and limits
Several sensitivity analyses were reported and a further 
strength of the methodology was use of bootstrapping to 
account for data skew [4]. The study employed a timeframe 
of 3 months as a trade-off between accuracy of recall and 
coverage, which was then generalised to estimate one-year 
societal costs, in line with previous work. This was both a 
strength and a limitation, risking underestimation of annual 
costs, although few cost imputation methods are free from 
bias [28]. Although participants were asked to consider costs 
related to their ED, costs associated with comorbidity were 
not estimated (e.g., [6, 17]) and absence of a control group 
prevented direct comparisons with other samples (e.g., see 
[10]). The questionnaire assessing healthcare use (see [25]) 
has not undergone psychometric evaluation and use of cen-
tralised sources for cost estimation (e.g., see [44]) may com-
plement ‘bottom-up’ studies such as the current one.
The human capital approach (see [35]) was used to esti-
mate costs, based on the assumption that wages are a proxy 
measure of productivity losses. Alternative approaches adopt 
different perspectives and may produce different cost esti-
mates (e.g., the friction cost approach; see [2, 35]). Several 
other assumptions were made across economic analyses, 
likely resulting in an underestimate of the true costs of binge 
eating. Although participants were invited to detail costs 
related to their illness not assessed by the questionnaire, 
responses were sporadic and omitted from the final analy-
ses. Out-of-pocket expenses focused largely on transporta-
tion and may have overlooked costs directly related to binge 
eating (see [16]). Medication costs (which are complex to 
estimate [45]) were included as a Healthcare cost, thus likely 
underestimating costs to patients, although the economic 
burden is nonetheless captured in the societal estimate.
The societal estimate is considered ‘limited’ [3] as several 
costs were not captured, contributing to a probable under-
estimation of associated costs. Provision of informal care 
can be substantial [5] and there was no estimate of the eco-
nomic impact of caring for someone with an ED, such as 
time spent attending joint appointments, and no assessment 
of expenditure on private treatment, which has been noted 
in previous UK studies [21]. Some questionnaire responses 
were missing information (e.g., number of visits to a health-
care professional), and the resulting assumptions also likely 
underestimated costs.
The current study is one of the first to estimate societal 
costs of EDs focusing on a sample characterised by regular 
binge eating in the absence of low weight. Although this 
population is at low risk of hospital admission [43], costs 
associated with both healthcare use and productivity losses 
were high, and comparable with previous estimates for simi-
lar disorders. Findings highlight the significant cost of EDs 
in individuals who are not underweight (those most com-
monly seen in clinical practice) and underscore the need 
for efficacious and cost-effective interventions. Paired with 
emerging data regarding traditional underinvestment in ED 
research [20], the findings should act as a call-to-arms to 
stimulate funding and direction of resources to reduce the 
burden of EDs.
What is already known on this subject?
Existing cost estimates have highlighted the huge eco-
nomic burden of EDs, costing society between €10,000 and 
€14,000 per person per year. However, several important 
limitations of previous work necessitate further studies in 
this area.
What does this study add?
The current study looks at individuals reporting regular 
binge eating in the absence of low weight—perhaps the 
largest subgroup of EDs presenting to clinical services. The 
findings are in line with previous estimates (costs to soci-
ety of €3758.74 per individual per annum) and suggest that 
greater investment in the treatment of binge eating is needed 
although few reliable correlates of cost were identified.
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